'''Methoxyketamine''' or '''2-MeO-2-deschloroketamine''' is a [[designer drug]] of the [[arylcyclohexylamine]] class first reported in 1963.<ref>{{ cite patent | country = BE | number = 634208 | title = Amino ketones | pubdate = 1963 | inventor = Stevens, Calvin L.}}</ref> It is an [[analog (chemistry)|analog]] of [[ketamine]] in which the chlorine atom has been replaced with a [[methoxy group]].  Its synthesis by rearrangement of an amino ketone has been reported.<ref>{{cite journal | doi = 10.1021/jo01346a034 | title = Amino Ketone Rearrangements. VII.1 Synthesis of 2-Methylamino-2-Substituted Phenylcyclohexanones | year = 1966 | last1 = Stevens | first1 = Calvin L. | last2 = Thuillier | first2 = Andre | last3 = Taylor | first3 = K. Grant | last4 = Daniher | first4 = Francis A. | last5 = Dickerson | first5 = James P. | last6 = Hanson | first6 = Harry T. | last7 = Nielsen | first7 = Norman A. | last8 = Tikotkar | first8 = N. A. | last9 = Weier | first9 = Richard M. | journal = The Journal of Organic Chemistry | volume = 31 | issue = 8 | pages = 2601 }}</ref> As an arylcyclohexylamine, methoxyketamine most likely functions as an [[NMDA receptor antagonist]]. It may produce sedative, hallucinogenic, and (at high doses) anesthetic effects.
